Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: February 2011
-
By Donald Zuhn — USPTO and IMPI Establish Patent Prosecution Highway (PPH) Pilot Program On Friday, the U.S. Patent and Trademark Office announced that it was establishing a new Patent Prosecution Highway (PPH) pilot program with the Mexican Institute of Industrial Property (IMPI). As with other PPH programs, the new PPH pilot will permit an…
-
By Juan Serrano — The Federal Commission for Protection Against Sanitary Risks (COFEPRIS) is the Mexican equivalent of the U.S. Food and Drug Administration (FDA). For the past three years this Commission was headed by Miguel Angel Toscano, who had previously held a position at the Ministry of Economy. Mr. Toscano's exit from COFEPRIS has…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Medicines Company v. Mylan Inc. et al.1:11-cv-01285; filed February 23, 2010 in the Northern District of Illinois • Plaintiff: The Medicines Company• Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc.; Bioniche Pharma USA, LLC Infringement of U.S.…
-
March 2, 2011 – Biotechnology/Chemical/Pharmaceutical (BCP) Customer Partnership Meeting (U.S. Patent and Trademark Office) – 10:00 am – 4:15 pm (Eastern) March 2, 2011 – "KSR and the Ripple Effect: Examining the Broad and Increasing Impact of KSR on Patent Litigation and Practice" (American Intellectual Property Law Association) – 12:30 – 2:00 pm (Eastern) March…
-
American Conference Institute (ACI) will be holding its next Paragraph IV Disputes conference on May 3-4, 2011 in New York, NY. The conference will allow attendees to: • Decipher the proposed revision to the standard of invalidity under Microsoft v. i4i;• Assess the evolving state of the law on double patenting type obviousness;• Analyze the…
-
The U.S. Patent and Trademark Office has announced the agenda for the next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting to be held on March 2, 2011. The proposed agenda is as follows: Morning Session • Greetings and Overview (10:00 – 10:15 am EDT): Jackie Stone, George Elliott, and Remy Yucel, Directors, Technology Center 1600 • Protest…
-
The George Washington University Law School will be holding an Intellectual Property Panel Symposium on March 18, 2011 at The Ritz Carlton-San Francisco in San Francisco, CA. The Symposium will offer panel discussions on the following topics: • 9:15 – 10:15 am — "Intellectual Property in the Modern Boardroom: Major Issues Facing General Counsels, CEO's…
-
The American Intellectual Property Law Association (AIPLA) will be offering a web-based program entitled "KSR and the Ripple Effect: Examining the Broad and Increasing Impact of KSR on Patent Litigation and Practice " on March 2, 2011 from 12:30 – 2:00 pm (Eastern). Jeffrey I. D. Lewis of Patterson Belknap Webb & Tyler LLP and…
-
By Donald Zuhn — After six years of committee debate, all indications are that the Senate will finally take up patent reform legislation by mid-March (see "Patent Reform Legislation Moves to Senate Floor"). Earlier this month, we reported on the reaction of several groups to the passage of the Senate bill (S. 23) out of…
-
By Donald Zuhn — Today, in Centocor Ortho Biotech, Inc. v. Abbott Laboratories, the Federal Circuit reversed the District Court's denial of judgment as a matter of law ("JMOL") of invalidity, holding the asserted claims of U.S. Patent No. 7,070,775 invalid for lack of written description. Plaintiffs-Appellees Centocor Ortho Biotech, Inc. and New York University…
Patent Docs 